Effect of self-microemulsifying system on cell tight junctions

Yaoxue Xuebao

Volumn 41, Issue 1, 2006, Pages 30-35

  Sha, Xian Yi ^a   Fang, Xiao Ling ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Caco 2 cells; Cell tight junction; Oral absorption; Self microemulsifying system

Indexed keywords

ACTIN; CREMOPHOR; DIETHYLENE GLYCOL MONOETHYL ETHER; DRUG DERIVATIVE; ETHYLENE GLYCOL DERIVATIVE; GLYCEROL; LABRASOL; MANNITOL; MEMBRANE PROTEIN; ORGANIC COMPOUND; PHOSPHOPROTEIN; ZONULA OCCLUDENS 1 PROTEIN; ZONULA OCCLUDENS-1 PROTEIN;

ARTICLE; CELL MEMBRANE; CELL STRAIN CACO 2; CELL SURVIVAL; DRUG DELIVERY SYSTEM; DRUG EFFECT; EMULSION; HUMAN; IMPEDANCE; METABOLISM; PROTEIN TRANSPORT; TIGHT JUNCTION;

ACTINS; CACO-2 CELLS; CELL MEMBRANE; CELL SURVIVAL; DRUG DELIVERY SYSTEMS; ELECTRIC IMPEDANCE; EMULSIONS; ETHYLENE GLYCOLS; GLYCEROL; HUMANS; MANNITOL; MEMBRANE PROTEINS; ORGANIC CHEMICALS; PHOSPHOPROTEINS; PROTEIN TRANSPORT; TIGHT JUNCTIONS;

EID: 33644789659     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Pouton CW. Formulation of self-emulsifying drug delivery system [J]. Adv Drug Deliv Rev, 1997,25:47-58.
2. Pouton CW. Lipid formulations for oral administration of drugs: non-emusifying, self-emulsifying and "self-microemulsifying" drug delivery systems [J]. Eur J Pharm Sci, 2000,11:S93-98.
3. O' Driscoll CM. Lipid-based formulations for intestinal lymphatic delivery [J]. Eur J Pharm Sci, 2002,15:405-415.
4. Kommuru TR, Gurley B, Khan MA, et al. Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessment [J]. Int J Pharm, 2001,212:233-246.
5. Constantinides PP. Lipid microemulsions for improved drug dissolution and oral absorption: physical and biopharmaceutical aspects [J]. Pharm Res, 1992,12:1561-1571.
6. Sakai M, Imai T, Ohtake H, et al. Effect of absorption enhancers on cytoskeletal actin filaments in caco-2 cell monolayers [J]. Life Sci, 1998,63:45-54.
7. Liu DZ, Lecluyse EL, Thakker DR. Dodecylphosphocho-line-mediated enhancement of paracellular permeability and cytotoxicity in caco-2 cell monolayers [J]. J Pharm Sci, 1999,88:1161-1168.
8. Sha XY, Fang XL. Transport characteristics of 9-nitrocamptothecin in the human intestinal cell line Caco-2 and everted gut sacs [J]. Int J Pharm, 2004,272:161-171.
9. Dorkoosh FA, Broekhuizen CA, Borchard G, et al. Transport of octreotide and evaluation of mechanism of opening the paracellular tight junctions using superporous hydrogel polymers in caco-2 cell monolayers [J]. J Pharm Sci, 2004,93:743-752.
10. Lindmark T, Kimura Y, Artursson P. Absorption enhancement through intracelluar regulation of tight junction permeability by medium chain fatty acids in Caco-2 cells [J]. J Pharmacol Exp Ther, 1998,284:364-369.
11. Suzuki A, Morishita M, Kajita M, et al. Ehanced colonic and rectal absorption eicospaentaenoic acid and docosahexaenoic acid [J]. J Pharm Sci, 1998,87:1196-1202.
12. Liu DZ, Morris-Natschke SK, Kucera LS, et al. Struture activity relationships for enhancement of paracellular permeability by 2-alkyoxy-3-alkylamidopropylphosphocho-lines across Caco-2 cell monolayers [J]. J Pharm Sci, 1999,88:1169-1174.
13. Fasano A, Nataro JP. Intestinal epithelial tight junctions as targets for enteric bacteria-derived toxins [J]. Adv Drug Deli Rev, 2004,56:795-807.
14. Lapierre LA. The molecular structure of the tight junction [J]. Adv Drug Deli Rev, 2000,41:255-264.
15. Gershanik T, Haltner E, Lehr CM, et al. Charge-dependent interaction of self-emulsifying oil formulations with Caco-2 cells monolayers: binding, effects on barrier function and cytotoxicity [J]. Int J Pharm, 2000,211:29-36.